214 related articles for article (PubMed ID: 26631082)
1. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z
BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
[TBL] [Abstract][Full Text] [Related]
3. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
Dorey L; Pelligand L; Lees P
BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
[TBL] [Abstract][Full Text] [Related]
4. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
[TBL] [Abstract][Full Text] [Related]
7. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
Dorey L; Lees P
BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Dorey L; Hobson S; Lees P
Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats.
Bhardwaj P; Sidhu PK; Lonare MK; Kaur R; Dumka VK; Rampal S
Res Vet Sci; 2018 Dec; 121():111-115. PubMed ID: 30384141
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of danofloxacin in healthy and Pasteurella multocida infected ducks.
Xiao X; Lan W; Wang Y; Jiang L; Jiang Y; Wang Z
J Vet Pharmacol Ther; 2018 Dec; 41(6):912-918. PubMed ID: 30182430
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S
J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
[TBL] [Abstract][Full Text] [Related]
14. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
[TBL] [Abstract][Full Text] [Related]
15. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves.
Balaje RM; Sidhu PK; Kaur G; Rampal S
Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961
[TBL] [Abstract][Full Text] [Related]
16. A new pleuromutilin candidate with potent antibacterial activity against Pasteurella multocida.
Fu Y; Ma L; Yi Y; Fan Y; Liang J; Shang R
Microb Pathog; 2019 Feb; 127():202-207. PubMed ID: 30529392
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
[TBL] [Abstract][Full Text] [Related]
18. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
Dorey L; Hobson S; Lees P
Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
[TBL] [Abstract][Full Text] [Related]
19. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.
Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH
BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
Xiao XM; Xiao YH
Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
